Debottam Sinha

37 Kent Street
Woolloongabba, QLD 4102, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Redox-active nitroxides enhance cisplatin efficacy against cervical cancer.

Redox-active nitroxides enhance cisplatin efficacy against cervical cancer.

Journal: Redox biology

Published: November 10, 2025

An α-specific PI3K inhibitor improves chemotherapy efficacy by inhibiting hepatic stellate cell activation in liver cancer.

An α-specific PI3K inhibitor improves chemotherapy efficacy by inhibiting hepatic stellate cell activation in liver cancer.

Journal: Hepatology (Baltimore, Md.)

Published: July 09, 2025

Depleting the Action of EZH2 through PI3K-mTOR Inhibition to Overcome Metastasis and Immunotherapy Resistance in Triple-Negative Breast Cancer.

Depleting the Action of EZH2 through PI3K-mTOR Inhibition to Overcome Metastasis and Immunotherapy Resistance in Triple-Negative Breast Cancer.

Journal: Molecular cancer therapeutics

Published: August 14, 2024

Characterization of the skin microbiome in normal and cutaneous squamous cell carcinoma affected cats and dogs.

Characterization of the skin microbiome in normal and cutaneous squamous cell carcinoma affected cats and dogs.

Journal: mSphere

Published: March 26, 2024

Peritumoral administration of immunomodulatory antibodies as a triple combination suppresses skin tumor growth without systemic toxicity.

Peritumoral administration of immunomodulatory antibodies as a triple combination suppresses skin tumor growth without systemic toxicity.

Journal: Journal for immunotherapy of cancer

Published: January 11, 2024

Molecular mechanisms augmenting resistance to current therapies in clinics among cervical cancer patients.

Molecular mechanisms augmenting resistance to current therapies in clinics among cervical cancer patients.

Journal: Medical oncology (Northwood, London, England)

Published: January 23, 2023

Repurposing of Commercially Existing Molecular Target Therapies to Boost the Clinical Efficacy of Immune Checkpoint Blockade.

Repurposing of Commercially Existing Molecular Target Therapies to Boost the Clinical Efficacy of Immune Checkpoint Blockade.

Journal: Cancers

Published: October 24, 2022

EBV and myeloid-derived suppressor cells.

EBV and myeloid-derived suppressor cells.

Journal: Blood

Published: January 14, 2021

'Off-the-shelf' allogeneic antigen-specific adoptive T-cell therapy for the treatment of multiple EBV-associated malignancies.

'Off-the-shelf' allogeneic antigen-specific adoptive T-cell therapy for the treatment of multiple EBV-associated malignancies.

Journal: Journal for immunotherapy of cancer

Published: January 10, 2021

Cep55 regulation of PI3K/Akt signaling is required for neocortical development and ciliogenesis.

Cep55 regulation of PI3K/Akt signaling is required for neocortical development and ciliogenesis.

Journal: PLoS genetics

Published: December 23, 2020

Pretransplant Cytomegalovirus-Specific Cellular Immunity and Risk of Viral Reactivation Following Lung Transplantation: A Prospective Cohort Study.

Pretransplant Cytomegalovirus-Specific Cellular Immunity and Risk of Viral Reactivation Following Lung Transplantation: A Prospective Cohort Study.

Journal: The Journal of infectious diseases

Published: October 14, 2020

Joining Forces: Improving Clinical Response to Cellular Immunotherapies with Small-Molecule Inhibitors.

Joining Forces: Improving Clinical Response to Cellular Immunotherapies with Small-Molecule Inhibitors.

Journal: Trends in molecular medicine

Published: February 24, 2020

Showing 1-12 of 21

Last Updated: 09/26/2026